#Immunoengineering
The November 2026 issue of #ScienceImmunology is live!

This month's cover depicts immune cells being modified directly within the body, highlighting a new Review on in vivo immunoengineering.

Learn about this work and more: https://scim.ag/3Va099G
November 9, 2026 at 10:00 PM
Master of Engineering student Amirhossein Moghtader joined UChicago PME’s Bio- and Immunoengineering Track to build on his clinical experience in vision screening and ocular surface regeneration research. 🧪

Apply now! The Round 1 deadline is Nov 12: ms.spr.ly/63325ah27H
Getting to the root of the problem through research
From screening children's vision to ocular regeneration research, master's student Amirhossein Moghtader wants to treat disease at its source.
ms.spr.ly
November 11, 2026 at 6:10 PM
The November 2026 issue of Science Immunology is live!

This month's cover depicts immune cells being modified directly within the body, highlighting a new Review on in vivo immunoengineering.

Learn about this work and more: scim.ag/4zBtysy
Contents | Science Immunology 11, 125
scim.ag
November 10, 2026 at 6:16 PM
What if a vaccine could help tackle high cholesterol?

At #CTGCTDay2026, Špela Malenšek (@kemijski.bsky.social ) will present her work on:
“Immunoengineering genetically encoded chimeric PCSK9 vaccine against hypercholesterolemia”

Free registration: forms.cloud.microsoft/e/inxvq4Kbyc
October 15, 2026 at 12:31 PM
We are thrilled to share that an #AITHYRA - #EPFL Consortium has been selected as one of 17 recipients of the #Googleorg Impact Challenge: AI for Science! The team will work on "Beyond Serendipity: Using Generative AI to Decode Viral Hijacking for Rational Drug Design". goo.gle/gic-ai-science
October 14, 2026 at 10:03 AM
CAR T cell therapies: since 2017, game-changer in cancer treatment. Transforming B-cell cancers with durable remissions. PMID:42393377, Nat Rev Immunol 2026, @NatRevImmunol https://doi.org/10.1038/s41577-026-01322-1 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
A guide to CAR T cell therapies: development, current status and future prospects | Nature Reviews Immunology
Since the first clinical approval in 2017, chimeric antigen receptor (CAR) T cell therapy has emerged as one of the most powerful modalities for redirecting the immune response against cancer. Building on decades of foundational discoveries in T cell biology and synthetic immunoengineering, CAR T cell therapy has transformed the treatment of B cell malignancies, resulting in durable remissions in patients with B cell leukaemias, lymphomas and multiple myeloma. Next-generation CAR designs are now expanding the reach of this approach into autoimmune disease and solid tumours. Innovations in gene editing, allogeneic manufacturing and in vivo delivery are improving the scalability, safety and accessibility of CAR T cell therapies, although challenges persist in overcoming antigen heterogeneity and tumour microenvironmental barriers and in promoting the long-term persistence of CAR T cells. In this Review, we summarize the key discoveries that laid the foundations for CAR T cell therapies a
doi.org
October 12, 2026 at 2:00 PM
Do you work in nanoengineering for #biomaterials and medicine? Nanoscale Advances would love to receive your latest primary research article as part of a themed collection on these topics. Find out more and submit⬇️

www.rsc.org/publishi...

#Immunoengineering #Biosensors #Nanobiotechnology
October 12, 2026 at 1:00 PM
Georgia Tech Academics Digest — September 23, 2026: Communication Skills, Data Science, and Immunoengineering

Wednesday brought a trio of Georgia Tech announcements spanning professional development, artificial intelligence research, and the frontier of immune medicine. Here's what's ahead on the…
Georgia Tech Academics Digest — September 23, 2026: Communication Skills, Data Science, and Immunoengineering
Wednesday brought a trio of Georgia Tech announcements spanning professional development, artificial intelligence research, and the frontier of immune medicine. Here's what's ahead on the Flats.
gtjackets.com
September 27, 2026 at 3:28 PM
I like the addition of immunoengineering!
🌴 Mark your calendars! Abstract submission for #IMMUNOLOGY2027™ will open on October 6!

Join thousands of leading researchers, innovators, and peers in sunny LA to share your latest scientific breakthroughs with the global #immunology community.

🔗 immunology2027.aai.org.
September 23, 2026 at 1:07 PM
Through #UChicago PME’s City Colleges of Chicago Summer Program, students spend three weeks exploring immunoengineering, quantum engineering and materials for sustainability.

🧪 Read more: ms.spr.ly/63324agEia
Summer program helps City Colleges students turn curiosity into a career
The City Colleges of Chicago Summer Program at UChicago PME gives students an introduction to STEM research and careers.
ms.spr.ly
September 23, 2026 at 5:00 PM
The COVID-19 pandemic sparked PhD student Trevor Ung’s interest in immunity. At UChicago PME, he is working to develop #vaccines that provide longer-lasting immunity.

🧪 Learn more about PhD programs at UChicago PME: pme.uchicago.edu/news-events/...
From the pandemic, an inspiration to study immunoengineering
PhD student Trevor Ung is working to make vaccines last longer by giving them a new target.
pme.uchicago.edu
September 17, 2026 at 4:36 PM
Do you work in #nanoengineering for #biomaterials and #medicine? Nanoscale Advances would love to receive your latest research for a themed collection on these topics. Find out more and submit ⬇️

www.rsc.org/publishi...

#bionanomaterials #bioprinting #regenerativemedicine #immunoengineering
September 17, 2026 at 9:00 AM
PhD Research Opportunity | Spring 2027
Biomaterials • Cancer Immunotherapy • Tissue Engineering
Advanced Immunoengineering for Translational Medicine Laboratory
Department of Chemical and Biochemical Engineering | Missouri S&T | Rolla, Missouri
September 16, 2026 at 6:45 AM
Extract: The Department of Bioengineering at Rice University seeks applications for a tenure-track Assistant Professor position starting July 1, 2027. Candidates in cancer bioengineering, immunoengineering, neuroengineering, and related fields are encouraged to apply.
September 13, 2026 at 6:12 AM
Exciting talks and inspiring insights await you 🧬🔬 We look forward to welcoming our speakers 😊
@efis-immunology.bsky.social @iuis-online.bsky.social @dgfi-yi.bsky.social @labminguet.bsky.social
@msubklewe.bsky.social @fau.de
 
#immunology26 #Immunotherapy #Immunoengineering
September 11, 2026 at 11:53 AM
September 6, 2026 at 8:41 AM
September 6, 2026 at 9:04 AM
The Correia Lab at EPFL focuses on developing computational tools for protein design and immunoengineering, integrating method development with the experimental characterization of designed proteins.
September 3, 2026 at 11:13 AM
After four years in pharmaceutical quality control, Master of Engineering student Akasha Ashraf came to UChicago PME to better understand how therapies are built from the ground up. #AcdemicSky

🧪 Learn more about the Master of Engineering experience. Apply now!
ms.spr.ly/63323aPIcb
Transitioning from quality control to the cutting edge of immunoengineering
After four years in pharmaceutical quality control, master's student Akasha Ashraf came to UChicago PME to understand how therapies are built from the ground up - and discovered a passion for engineering the immune system itself.
ms.spr.ly
August 26, 2026 at 3:53 PM
Icahn Mount Sinai is proud to partner with @rpi to offer a joint Ph.D. program in health sciences engineering. Beginning in the fall semester of 2025, the program will focus on reparative and regenerative medicine, immunoengineering, and neuroengineering. bit.ly/3CD2mB3
Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai to Offer Joint Ph.D. Program in Health Sciences Engineering | News
Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai will offer a joint Ph.D. program in health sciences engineering beginning in the fall semester of 2025. RPI is a ...
bit.ly
November 21, 2024 at 3:59 PM
Loving seeing the growing biomaterials (go.bsky.app/DymaVAp) and immunoengineering (go.bsky.app/DhAhgyB) community here & I am happy to keep adding folks to these starter packs with self nominations to either of them.

Just let me know which you want to be added to
Bluesky
Social media as it should be. Find your community among millions of users, unleash your creativity, and have some fun again.
go.bsky.app
November 21, 2024 at 2:48 AM
While we are at it, I am also trying to put together an Immunoengineering Starter Pack, but we don't have enough folks yet to create it. If you're an engineer working on immune-related topics, reach out to me and let me know so we can all find one another.
November 11, 2024 at 2:56 PM